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Abstract ArtinM is a D-mannose-binding lectin extracted
from Artocarpus heterophyllus that promotes interleukin-12
production by macrophages and dendritic cells. This property
is considered responsible for T helper 1 immunity induced
in vivo after ArtinM administration. In this study, we investi-
gated the effect of native (jArtinM) and recombinant
(rArtinM) forms of lectin on murine spleen cells and isolated
T lymphocytes. We found that ArtinM binds to the surface of
spleen cells. This interaction, which was blocked by D-
mannose, induced cell activation, as manifested by increased
mitochondrial activity, interleukin-2 production, and cell pro-
liferation. We verified that a 30-times higher concentration of
rArtinM was required to trigger optimal activation of spleen
cells compared with that needed with jArtinM, although these
proteins have identical sugar recognition properties and use
the same signaling molecules to trigger cell activation.
Because the distinction between native and recombinant is
restricted to their tertiary structure (tetrameric and monomeric,
respectively), we postulated that the multi-valence of jArtinM
accounts for its superiority in promoting clustering of cell
surface glycoreceptors and activation. The jArtinM and
rArtinM activation effect exerted on spleen cells was
reproduced on purified CD4+ T cells. Our results suggest that
ArtinM interaction with Tcells leads to responses that may act
in concert with the interleukin-12 produced by antigen-
presenting cells to modulate immunity toward the T helper 1
axis. Further studies are necessary to dissect ArtinM/T-cell
interactions to more fully understand the immunomodulation
induced by carbohydrate recognition.
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Introduction
Lectins are proteins with at least one non-catalytic domain that
binds reversibly and specifically to a mono- or oligosaccha-
ride (Peumans and Van Damme 1995). They are ubiquitous in
nature, being found in organisms from viruses to humans
(Sharon 2008). Lectins are involved in numerous biological
activities, including promotion of cell–cell and cell–extracel-
lular matrix interactions, complement system activation, in-
duction of leukocyte activation and migration, induction of
cytokine production, adhesion of pathogens to host cells, and
induction of cell death (Sharon and Lis 2004). Most often, the
biological activities of lectins depend on their carbohydrate
recognition domain (CRD), which interacts with cell surface
glycoproteins (Baba et al. 2007) that trigger cell signaling.
ArtinM, a D-mannose-binding lectin, obtained from the
seeds of Artocarpus heterophyllus, is organized as a
homotetramer formed by 16-kDa non-glycosylated subunits
(Santos-de-Oliveira et al. 1994). Each polypeptide chain con-
tains a CRD with affinity to Manα 1–3 [Manα 1–6] Man,
which corresponds to the core N-linked oligosaccharides. The
following activities are attributed to ArtinM: (1) neutrophil
activation, triggered by binding to N-glycans on Toll-like
receptor 2 (TLR2) and chemokine receptor (CXCR2)
(Ganiko et al. 1998; Pereira-da-Silva et al. 2006; Santos-de-
Oliveira et al. 1994), (2) mast cell degranulation induced by
interactions with N-glycans of FcεR or N-glycans of immu-
noglobulin E-linked FcεR (Moreno et al. 2003), and (3)
production of interleukin (IL)-12 stimulated by recognition
ofN-linked glycans of the TLR2 ectodomain on the surface of
macrophages and dendritic cells (Coltri et al. 2008). The
induction of IL-12 production is considered a central effect
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because ArtinM administration drives immunity toward the T
helper (Th) 1 axis (Panunto-Castelo et al. 2001; Teixeira et al.
2006), conferring resistance to infections by intracellular
pathogens such as Leishmania major (Panunto-Castelo
et al. 2001), L. amazonensis (Teixeira et al. 2006),
Paracoccidioides brasiliensis (Coltri et al. 2008, 2010),
Neospora caninum (Cardoso et al. 2011), and Candida
albicans (Custodio et al. 2011).
The ArtinM immunomodulatory property is exerted by
both lectin forms, native (jArtinM) and recombinant
(rArtinM) (daSilva et al. 2005; Pranchevicius et al. 2012),
which structurally differ in terms of oligomerization. In oppo-
sition to the tetrameric structure of native ArtinM, the recom-
binant counterpart, obtained by expression in Escherichia
coli, is monomeric. The availability of native and recombinant
ArtinM provides convenient tools with which to investigate
the requirements for triggering cell signaling.
Regarding the mechanisms accounting for ArtinM immu-
nomodulatory properties, IL-12 production due to lectin inter-
action with TLR2 on macrophages and dendritic cells has
been well exploited. However, the possibility that the effects
of ArtinM extend to lymphoid cells and establish interactions
that contribute to immunomodulation has not been investigat-
ed. In the present study, the activities exerted by native and
recombinant ArtinM onmurine spleen cells were examined. A
direct effect on T cells was verified, providing new elements
for full comprehension of the immunomodulation promoted




Animal studies were approved by the Ethical Committee of
Ethics in Animal Research of the College of Medicine of
Ribeirão Preto of the University of São Paulo and were
conducted in accordance with the Ethical Principles in
Animal Research adopted by the Brazilian College of
Animal Experimentation, Protocol no. 082/2012.
Animals
Male BALB/c, C57BL/6, TLR2 KO, and TLR4 KO mice
were acquired from the animal house of the Campus of
Ribeirão Preto, University of São Paulo, Ribeirão Preto, São
Paulo, Brazil, and housed in the animal facility of the
Molecular and Cellular Biology Department of the Faculty
of Medicine of Ribeirão Preto, University of São Paulo, under
optimized hygienic conditions. All experiments were conduct-
ed in accordance with the ethical guidelines of the animal
studies ethics committee. The experimental mice were used
at 6–8 weeks of age.
Lectins
jArtinM was purified as previously described (Santos-de-
Oliveira et al . 1994) from the saline extract of
A. heterophyllus (jackfruit) seeds via affinity chromatography
on sugar columns. rArtinMwas expressed in E. coliBL21 and
purified as previously reported (daSilva et al. 2005). Before
use, preparations of jArtinM and rArtinM were incubated for
1 h with polymyxin solution (Sigma-Aldrich, St. Louis, MO,
USA). Concanavalin A (ConA) from Canavalia ensiformis
was purchased from Sigma Chemical.
Suspensions of spleen cells and isolated CD4+ T cells
Mice spleens were removed aseptically and transferred to a
Petri dish where they were soaked and filtered in a 40-μm
nylon cell strainer (BD Biosciences, San Diego, CA, USA)
containing Roswell Park Memorial Institute (RPMI) 1640
medium. The cellular suspension was centrifuged at 300g
(10 min at 4 °C) to yield a pellet. The suspension was
erythrocyte-depleted with lysing buffer (9 parts 0.16 M am-
monium chloride and one part 0.17 M Tris–HCl, pH 7.5) for
10 min at 4 °C. The spleen cells were then washed twice in
10 % fetal cow serum (FCS)/RPMI 1640 and centrifuged at
300g (10 min at 4 °C). Cells were counted in a Neubauer
chamber, and their viability was determined using the trypan
blue exclusion method. Viability of the spleen cells was great-
er than 90 %.
CD4+ T cells were isolated from spleen cell suspensions
using CD4+ Tcell isolation kits II andMS columns, both from
Miltenyi-Biotec (Auburn, CA, USA) according to the manu-
facturer’s instructions. To assess purity, negatively selected
cells were stained with anti-CD4 PE-Cy5 antibody (BD
Biosciences) and analyzed with flow cytometry (Guava
easyCyte, Guava Technologies, Millipore). Purity grades of
92–95 % were achieved.
IL-2 measurement in cell supernatants
Spleen cells (1.5×106/mL) were cultured in the presence of
jArtinM (0.14–156.00 nM), rArtinM (0.56–625.00 nM) or
ConA (49.0 nM) in 96-well microplates. After 12, 24, 48,
and 72 h of incubation, the spleen cells were centrifuged
(300g, 10 min at room temperature), and the supernatants
were collected to measure IL-2 levels using an enzyme-
linked immunosorbent assay from Kit OptEIA (BD
Biosciences) according to the manufacturer’s instructions.
Similar procedures were performed to determine IL-2 levels
in the supernatants of isolated CD4+ T cells.
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3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay
Spleen cells distributed and stimulated as described for IL-2
detection were assayed for the reduction of MTT (Sigma-
Aldrich) and production of formazan crystals (Mosmann
1983). MTT solution (500 μg/mL in RPMI 1640 containing
10% FCS) was added (100 μL) to the wells containing spleen
cells. The microplates were incubated for 3 h 30 min at 37 °C
in a humidified atmosphere of 5 % CO2. The cells were then
centrifuged (300g, 10 min at room temperature), the superna-
tants were removed, and 100 μL dimethyl sulfoxide was
added to the wells. After overnight incubation at room tem-
perature, the absorbance was read at 570 nm using a spectro-
photometer (Power Wave X; BioteK Instruments).
Mitochondrial activity was expressed as absorbance variation
(as a percentage) in relation to the negative control and calcu-
lated as follows: [(optical density value in stimulated cells/
average optical density value in unstimulated cells) −1]×100.
The positive or negative percentage values represent the in-
crease or decrease in mitochondrial activity related to
unstimulated cells.
Cell proliferation assay
Spleen cells (1.5×106/mL) were distributed in a 96-well mi-
croplate and cultured in the presence of jArtinM (2.25 nM or
4.50 nM), rArtinM (78.00 nM or 156.00 nM), or ConA
(24.5 nM). The cells were cultured for 48 h, and, during the
last 12 h of incubation, tritiated thymidine ([3H]-TdR;
Amersham Bioscience, Boston, MA, USA) was added to the
wells (0.5 μCi/well). Cell proliferation was assessed by mea-
suring [3H]-TdR incorporation, and the results were expressed
in counts per minute (cpm).
Sugar inhibition assay of ArtinM activities
D-mannose (100 mM) or D-galactose (100 mM) was added to
jArtinM (2.25 nM), rArtinM (78.00 nM), or phorbol myristate
acetate (PMA; 81.0 nM) plus ionomycin (1.0 μM). After
30 min of incubation at 4 °C, the mixtures were distributed
in the wells of a microplate containing spleen cell suspension
(1.5×106 cell/mL) in a final concentration of 50 mM sugars.
The microplates were incubated at 37 °C in a humidified
atmosphere of 5 % CO2. The cells and supernatants were
analyzed for mitochondrial activity and IL-2 levels following
the protocols described earlier.
Cell activation after treatment with inhibitors of cell signaling
molecules
Spleen cells (1.5×106/mL) were incubated with the protein
tyrosine kinase inhibitor genistein (20 μg/mL), the p42/44
mitogen-associated protein kinase (MAPK) inhibitor
PD98059 (20 μM), the p38 MAPK inhibitor SB202190
(20 μM), the protein kinase C inhibitor H-7 (20 μM), or the
c-Jun N-terminal kinase (JNK) inhibitor SP600125 (25 μM)
for 3 h 30 min in RPMI 1640 with 10 % FCS at 37 °C in a
humidified atmosphere of 5 % CO2. The cells were then
stimulated with jArtinM (2.25 nM), rArtinM (78.00 nM),
PMA (81.0 nM) plus ionomycin (1.0 μM), or ConA
(49.0 nM) for 48 h. The cells and supernatants were analyzed
for mitochondrial activity and IL-2 levels following protocols
described earlier.
Flow cytometry analysis of ArtinM binding on spleen cells
Biotinylated ArtinM (20 μg/mL) was incubated for 45 min
with D-mannose or D-galactose (1 mM, 10 mM, 20 mM,
30 mM, or 50 mM) or with medium alone. These mixtures
were added to fixed (3 % formaldehyde-phosphate-buffered
saline) spleen cells (1.5×106/mL) that were then incubated for
30 min at room temperature. After two washes with
phosphate-buffered saline, bound biotinylated ArtinM on
spleen cells was reacted with streptavidin-fluorescein isothio-
cyanate (strp/FITC; 5 μg/mL; Invitrogen) for 40 min and
fluorescence staining was analyzed with flow cytometry
(Guava EasyCyte). The percentage of stained spleen cells
was then determined. To evaluate ArtinM binding on T cells,
we treated the spleen cells with bound ArtinM for an addi-
tional 40 min with anti-CD3 PE-Cy5 antibody (4 μg/mL; BD
Biosciences) and performed flow cytometry analysis. The
percentage of double-positive cells for each experimental
condition was then analyzed.
Competition assays between an anti-CD3 antibody
and ArtinM in relation to CD4+ T cells
The binding of ArtinM to CD3 receptor was determined on
CD4+ T cells isolated from spleen cell suspensions using
CD4+ T cell isolation kits II and MS columns from Miltenyi-
Biotec according to themanufacturer’s instructions. In the first
assay, the cells were fixed and incubated with ArtinM (25 μg/
mL) for 40 min at 4 °C. After two washes with phosphate-
buffered saline (PBS), the cells were incubated with an anti-
CD3 PE-Cy5 antibody (10 μg/mL; clone 17A2; BD
Biosciences) for 40 min at 4 °C. The percentage of labeled
cells was determined using flow cytometry (Guava
EasyCyte). A functional inhibition assay was carried out by
pre-incubating CD4+ Tcells with either the anti-CD3 antibody
(5 μg/mL) or an anti-CD28 antibody (5 μg/mL; clone 37.51;
BDBiosciences) for 40min at 4 °C. After washing with RPMI
medium, the cells were stimulated for 48 h with jArtinM
(78 nM). The culture supernatants were tested by means of
ELISA for IL-2.
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Statistical analysis
Results are presented as means ± standard error of the mean and
all data were analyzed using Prism (Graph Pad Software).
Statistical determinations of the difference between means of
groups were performed with analysis of variance (1-way)
followed by Bonferroni’s multiple comparison test. Differences
that provided p<0.05 were considered statistically significant.
Results
ArtinM binding on murine spleen cells
The binding of ArtinM on murine spleen cells was evaluated
by incubating the cells with biotinylated ArtinM (20 μg/mL)
and reacting them with strp/FITC. Analysis with flow cytom-
etry showed that approximately 90% of the cells were labeled
(Fig. 1). The hypothesis that the ArtinM CRD could mediate
binding on spleen cells led us to perform a sugar inhibition
assay. Based on the known selectivity of ArtinM sugar recog-
nition, D-mannose was used as an ArtinM ligand, and D-
galactose as a negative control. The proportion of ArtinM-
labeled cells decreased in a dose-dependent manner when the
lectin was preincubated with D-mannose, whereas D-
galactose had no effect on ArtinM binding on spleen cells
(see Fig. 1). The binding was inhibited up to 85–88 % when
D-mannose concentrations varied from 20 to 50 mM, and was
50 % inhibited by 10 mM. Otherwise, 1 mM D-mannose or
any D-galactose concentration tested had no significant effect
on ArtinM binding to the spleen cell surface. These results
suggest that glycans expressed on murine spleen cells are
targeted by ArtinM.
Mitochondrial activity in murine spleen cells stimulated
by jArtinM and rArtinM
To investigate whether the ArtinM interactions with
glycotargets on the spleen cell surface trigger cell activation,
we assessed the mitochondrial activity of ArtinM-stimulated
spleen cells by performing MTT assay. Two different ArtinM
preparations were tested. The first was jArtinM, which is the
native tetrameric protein purified from jackfruit seeds. The
other was rArtinM, the recombinant counterpart protein ob-
tained from lectin expression in E. coli BL21 and character-
ized as monomeric. At varying concentrations (0.1–625 nM),
these preparations were used to stimulate spleen cell cultures
for 12–72 h.
Increased mitochondrial activity of spleen cells was mostly
observed after 48 and 72 h of stimulation. jArtinM augmented
mitochondrial activity when used at concentrations of 0.14–
9 nM, and maximum activity (closed to that provided by
ConA, used as a positive control) was determined with
1.12–9 nM ArtinM (Fig. 2a). Stimulating similar mitochon-
drial activity required much higher concentrations of rArtinM.
Maximum activity was determined with 156 nM rArtinM,
which is a concentration 35 times higher than that of
jArtinM required to induce the activity peak (Fig. 2b). No
mitochondrial activity was detected when jArtinM concentra-
tions were equal or superior to 18 nM, suggesting that high
lectin concentrations may be toxic for the spleen cells (see
Fig. 2).
IL-2 production by spleen cells stimulated by jArtinM
and rArtinM
Because ArtinM binds to glycotargets on murine spleen cells
and increases mitochondrial activity, we investigated whether
jArtinM or rArtinM stimulation induced IL-2 production. At
concentrations from 0.14 to 36 nM, jArtinM significantly
increased IL-2 production by murine spleen cells, yielding a
bell-shaped dose–response curve that was more discernible
when cells were stimulated for 24 h. Maximum IL-2 levels
were determined with 2–9 nM jArtinM (Fig. 3a). Regarding
the response to rArtinM, significant augmentation of IL-2
production was determined using 78–625 nM (Fig. 3b).
Reaching peak IL-2 production required 4.5 nM jArtinM
and 156 nM rArtinM. Therefore, a concentration of rArtinM
35 times higher than that of jArtinM was necessary to induce
the highest levels of IL-2 production, which was close to that
induced by 49 nM ConA (positive control).
Spleen cell proliferation induced by jArtinM and rArtinM
Because both jArtinM and rArtinM stimulate mitochondrial
activity of murine spleen cells and IL-2 production, we
assayed their capacity to induce cell proliferative response
through the [3H]-TdR incorporation assay. The doses of
jArtinM and rArtinM that induced maximal mitochondrial
activity and IL-2 production were chosen as the lectin con-
centrations to be assayed for cell proliferation induction. We
used 2.25 nM and 4.5 nM jArtinM and 78 nM and 156 nM
rArtinM. The two doses of both lectin preparations promoted
spleen cell proliferation in levels closed to those determined
by the positive control, 24.5 nM ConA (Fig. 4).
Carbohydrate recognition in jArtinM and rArtinM stimulation
of spleen cells
Because ArtinM CRD accounts for binding on spleen cells, we
evaluated the role of carbohydrate recognition in cell activation
induction. The fact that mitochondrial activity and IL-2 produc-
tion were stimulated by jArtinM and rArtinM made these pa-
rameters suitable for sugar inhibition assays. The pre-incubation
of 2.25 nM jArtinM or 78.00 nM rArtinM with 50 mM D-
mannose inhibited 80 % of the mitochondrial activity induced
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by both ArtinM preparations and blocked the lectin property of
inducing IL-2 production by spleen cells. Otherwise, D-
mannose did not modify the activities of the positive control,
which was PMA plus ionomycin. We also observed that pre-
incubation of spleen cells with 50mMD-galactose had no effect
on spleen cell activation induced by ArtinM. These results
indicate that the jArtinM and rArtinM effects on spleen cells
are mediated by sugar recognition (Fig. 5).
Fig. 1 ArtinM binds to the surface of spleen cells through carbohydrate
recognition. Biotinylated jArtinM (20 μg/mL) was incubated with the
indicated concentrations of D-mannose (c–g) or D-galactose (h–l). The
resulting mixtures were added to a suspension (1.5×106 cells/mL) of
fixed spleen cells, which were obtained from BALB/c mice. ArtinM
binding was revealed by reaction with streptavidin-FITC (5 μg/mL).
Streptavidin-FITC alone was used as a negative control (a). The cells
were washed and analyzed for fluorescence intensity by flow cytometry.
Figures show the percentage of positive cells for ArtinM binding for each
experimental condition (b–l). The results are expressed as means ± SEM
and represent 3 independent experiments
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Spleen cell activation induced by ArtinM does not depend
on TLR2 or TLR4
Since ArtinM recognizes glycans on TLR2, we investigated
whether this interaction could account for the murine spleen
cell activation. For this, we evaluated ArtinM-mediated stim-
ulation of spleen cells isolated from TLR2 KO mice. Spleen
cells from TLR4 KO mice were also examined to exclude the
possibility of LPS contamination in the ArtinM preparations.
Typically, spleen cells were stimulated for 24 h with jArtinM
(9 nM) or rArtinM (312 nM), and were analyzed for mito-
chondrial activity as well as IL-2 production. Both analyses
showed that ArtinM as well as ConA similarly activated
spleen cells from WT and KO mice (Fig. 6). Mitochondrial
Fig. 2 ArtinM stimulates mitochondrial activity of spleen cells in a dose-
dependent manner. Murine spleen cells (1.5×106 cells/mL) fromBALB/c
were distributed in 96-well microplates and incubated at 37 °C in a
humidified atmosphere of 5 % CO2 and stimulated with jArtinM (a) or
rArtinM (b) in concentrations of 0.14–156 or 0.56–625 nM, respectively.
Non-stimulated spleen cells were used as negative controls. After 12, 24,
48, and 72 h of incubation, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) was added to the culture medium; MTT
reduction to insoluble purple formazan dye crystals was detected via
absorbance reading at 570 nm. Mitochondrial activity was expressed as
absorbance variation (in percentages) in relation to the negative control.
Stimulation with Concanavalin A (49 nM) was used as a positive control,
which provided the following absorbance variations: 114.9±4.7 (12 h),
240.6±40.58 (24 h), 852.7±22.41 (48 h), and 704.6±15.3 (72 h). The
results represent 3 independent experiments and are expressed as means ±
SEM
Fig. 3 ArtinM stimulates interleukin-2 (IL-2) production by spleen cells
in a dose-dependent manner. Spleen cells (1.5×106 cells/mL) from
BALB/c were distributed in 96-well microplates and incubated at 37 °C
in a humidified atmosphere of 5 % CO2 and stimulated with jArtinM (a)
or rArtinM (b) in concentrations of 0.14–156 or 0.56–625 nM, respec-
tively. After 12, 24, 48, and 72 h of incubation, the cell culture superna-
tants were analyzed for IL-2 levels with enzyme-linked immunosorbent
assay. Stimulation with Concanavalin A (49 nM), used as a positive
control, provided the following IL-2 levels: 465.60±4.49 (12 h), 495.8
±7.06 (24 h), 421.6±4.37 (48 h), and 431.3±6.73 (72 h). Non-stimulated
spleen cells, used as negative controls (medium), provided the following
IL-2 levels: 10.11±2.04 (12 h), 10.24±2.16 (24 h), 18.19±3.29 (48 h),
and 31.59±4.49 (72 h). The results represent 3 independent experiments
and are expressed as means ± SEM. *p<0.05 compared to the medium
for all incubation periods
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activity induced by LPS or Pam3Cys was absent in TLR4- or
TLR2-deficient spleen cells, respectively. Since these agonists
failed to induce IL-2 production after 24 h, we conclude that
TLR agonists and lectins induced spleen cells activation
through distinct mechanisms.
Signaling molecules in jArtinM-and rArtinM-induced spleen
cell activation
Considering that jArtinM and rArtinM have different oligo-
meric structures and induce spleen cell activation at distinct
concentrations, we questioned whether they used the same or
different signaling molecules to trigger the verified responses.
Several pharmacological inhibitors (genistein, H-7, PD98059,
SB202190, and SP600125) were then used to investigate the
possible signaling molecules involved in responses to
2.25 nM jArtinM or 78 nM rArtinM. After 3 h 30 min of
inhibitor treatment, cells were stimulated and analyzed for
mitochondrial activity and IL-2 production. A similar profile
of mitochondrial activity inhibition was associated with stim-
ulation by jArtinM and rArtinM, showing that p38 MAPK,
protein tyrosine kinase, and JNK are strongly involved in
signaling triggered by both lectin preparations (Fig. 7a). Our
results also demonstrated that IL-2 production was affected by
protein tyrosine kinase inhibitor and JNK inhibitor (Fig. 7b)
when stimulated by either jArtinM or rArtinM. Therefore,
specific signaling molecules responsible for spleen cell acti-
vation were involved in the responses to both, native and
recombinant ArtinM.
ArtinM binding on murine T cells
Considering that spleen cells encompass distinct cell popula-
tions that include T lymphocytes, we investigated whether
ArtinM recognized T cell glycans and induced the cell activa-
tion process observed when unseparated murine spleen cells
were used. Through flow cytometry, we first analyzed
jArtinM binding on spleen CD3+ cells. We verified that ap-
proximately 60% of the spleen cell suspension was stained for
CD3. Among these anti-CD3 stained cells, 97%were targeted
by jArtinM; i.e., they were double-labeled for CD3 and
jArtinM binding (Fig. 8). A proportion of 88 % of the cell
suspension was labeled with jArtinM, 48 % of them corre-
sponding to double-positive cells. These data indicate that T
lymphocytes are targeted by jArtinM and are candidates to
undergo the activation process induced by the lectin.
Fig. 4 Spleen cell proliferation induced by ArtinM. Spleen cells (1.5×
106 cells/mL) from BALB/c were distributed in a 96-well microplate and
incubated for 48 h at 37 °C in a humidified atmosphere with 5%CO2 and
stimulated with the indicated concentrations of jArtinM or rArtinM.
Medium alone and Concanavalin A (ConA) (24.5 nM) were used as
negative and positive controls, respectively. After 36 h of stimulation,
[3H]-thymidine (0.5 μCi/well) was added andmeasured for incorporation
(cpm) after 12 h of incubation. The results are expressed asmeans ± SEM.
*Significant differences with p<0.05 in relation to medium values
Fig. 5 Spleen cell activation by ArtinM depends on carbohydrate recog-
nition. Murine spleen cells (1.5×106 cells/mL) obtained from BALB/c
were distributed in a 96-well microplate and incubated at 37 °C in a
humidified atmosphere of 5 % CO2. The cells were stimulated with
jArtinM (2.25 nM) or rArtinM (78.00 nM) andwere previously incubated
or not with 50 mM D-mannose or D-galactose. Phorbol myristate acetate
(PMA; 81 nM) plus ionomycin (1 μM) was used as a positive control
stimulus. After 48 h of stimulation, mitochondrial activity (a) and IL-2
production (b) were determined. The results are expressed as % of
inhibition, obtained by relating the measurements in the presence and
absence of sugar for each stimulus. The results represent 3 independent
experiments
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IL-2 production by CD4+ T cells stimulated by jArtinM
and rArtinM
Because lymphocyte activation is manifested by IL-2 produc-
tion, and CD4+ T lymphocytes constitute a major IL-2 cell
source, we assayed the effect of jArtinM and rArtinM stimu-
lation on purified CD4+ T cells. After 48 h of incubation with
18, 36, or 78 nM jArtinM or 78, 156, or 312 nM rArtinM, IL-2
production was induced in a dose-dependent manner. Figure 9
shows that similar levels of IL-2 were produced by CD4+ T
cells stimulated with 36 nM jArtinM or 312 nM rArtinM,
demonstrating that rArtinM is approximately ten times less
effective than jArtinM for inducing lymphocyte activation.
CD3 as a biologically relevant glycotarget of ArtinM
The possibility that CD3 could be a glycotarget of ArtinM on
CD4+ Tcells was examined using an inhibition assay. Isolated
CD4+ T cells, preincubated with or without ArtinM, were
incubated with an anti-CD3 antibody. Flow cytometry analy-
sis showed that ArtinM drastically inhibited the cell labeling
with the anti-CD3 antibody (Fig. 10a–c). Because CD3 is
Fig. 6 TLR2 or TLR4 does not mediate spleen cell activation by ArtinM.
Murine spleen cells (1.5×106 cells/mL) from C57BL/6 (WT), TLR2 KO,
and TLR4 KO mice were plated onto 96-well microplates, incubated at
37 °C and 5%CO2 in a humidified incubator, and stimulated for 24 h with
9 nM jArtinM or 312 nM rArtinM. Pam3Cys (TLR2 agonist, 1.5 μg/mL),
LPS (TLR4 agonist, 1 μg/mL), or Concanavalin A (ConA) (49 nM), were
used as positive controls for stimulation, whereas the medium alone was
used as negative control. Next, the cells were analyzed for mitochondrial
activity (MTTassay) (a) and IL-2 production (ELISAmethod) (b). Results
are expressed as means ± SEM. *Differences in response from that ofWT
cells with p<0.05 was considered as significant
Fig. 7 Effect of inhibitor agents of molecules accounting for cell signal-
ing pathways on jArtinM- or rArtinM-induced activation of spleen cells.
PD98059 [p42/44 mitogen-associated protein kinase (MAPK) inhibitor;
20 μM], genistein (protein tyrosine kinase inhibitor; 20 μg/mL),
SB202190 (p38 MAPK inhibitor; 20 μM), SP600125 (c-Jun N-terminal
kinase inhibitor; 25 μM), H-7 (protein kinase C inhibitor; 20 μM), or
medium alone (absence of inhibitor) were used to pretreat, for 210 min,
murine spleen cells (1.5×106/mL) that were distributed in 96-well plates
and maintained at 37 °C in a humidified atmosphere with 5 % CO2. After
pretreatment, cells were stimulated with jArtinM (2.25 nM) or rArtinM
(78 nM) for 48 h. PMA (81 nM) plus ionomycin (1 μM) or Concanavalin
A (ConA) (49 nM) were positive controls for cell stimulation, whereas
medium alone provided the negative control. The cells were analyzed for
mitochondrial activity via MTTassay (a) and IL-2 production via ELISA
(b). Measurements are expressed as means ± SEM, and the inhibition
determined by each pharmacological agent was calculated by the ratio
between the values obtained in the presence of a certain inhibitor and in its
absence, represented by percentages
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known to be functionally important for T cell activation, we
tested the ability of the anti-CD3 antibody to block the
ArtinM-induced activation of CD4+ T cells. The cells were
preincubated with or without the anti-CD3 antibody and then
stimulated with ArtinM. An IL-2 assay in culture supernatants
showed that the anti-CD3 antibody inhibited the stimulatory
effect of ArtinM on CD4+ Tcells (Fig. 10d) and pointed to the
functional relevance of CD3 as a glycotarget of ArtinM. A
specific antibody against CD28, a costimulatory molecule that
also participates in the activation of T lymphocytes, was
unable to block the activation of CD4+ T cells by ArtinM
(Fig. 10d).
Discussion
The known ArtinM property of stimulating Th1 immunity
in vivo has been attributed to lectin interaction with TLR2
N-glycans on the surface of macrophages and dendritic cells.
The present study is the first systemized effort to investigate
the in vitro lectin effect on cells of adaptive immunity with the
Fig. 8 ArtinM binds to the
surface of T lymphocytes. Spleen
cells (1.5×106/ml) were fixed and
incubated for 40 min with anti-
CD3 PE-Cy5 antibody (4 μg/mL)
(b, d). After washing, the cells
were incubated for 40 min with
biotinylated ArtinM (15 μg/mL)
(c, d). ArtinM binding was
revealed by reaction for 40 min
with streptavidin-FITC (5 μg/
mL). Streptavidin-FITC and
Isotype PE-Cy5 were used as a
negative control (a). Cell
fluorescence was analyzed with
flow cytometry. Dot plots
represent the percentage of
positive cells obtained by
biotinyl-ArtinM + strp/FITC or
anti-CD3 PE-Cy5. The results are
expressed as means ± SEM
Fig. 9 jArtinM and rArtinM enhances IL-2 secretion in CD4+ T cells.
Purified CD4+ T cells (1×106 cells/mL) from a spleen cell suspension of
BALB/c mice were distributed in 96-well microplates and maintained at
37 °C in a humidified atmosphere with 5 % CO2. The CD4
+ T cells were
stimulated for 48 h with jArtinM (18, 36, or 78 nM) or rArtinM (78, 156,
or 312 nM). Concanavalin A (49 nM) was used as a positive control of
stimulation. Culture supernatants were analyzed for IL-2 production
using ELISA, and the results are expressed as means ± SEM. *Significant
differences when p<0.05 compared with medium values
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assumption that it could contribute to the immuno modulation
determined by ArtinM administration. By stimulating murine
spleen cells, ArtinM induces cell activation, as manifested by
increased mitochondrial activity, IL-2 production, and prolif-
eration. These activities were shown to depend on carbohy-
drate recognition and involve glycotargets on surface CD4+ T
cells.
The lymphoproliferative properties of plant lectins have
been reported extensively since the discovery that phytohe-
magglutinin (PHA) from Phaseolus vulgaris (Nowell 1960),
pokeweed mitogen from Phytolacca americana (Farnes et al.
1964), and concanavalinA from Canavalia ensiformis
(Wecksler et al. 1968) stimulate lymphocytes to undergo
mitosis. The application of mitogenic lectins as tools in bio-
medical research gained force when PHA-activated human
lymphocytes were shown to secrete a T cell growth factor,
now known as IL-2. Subsequently, activated immune cells
were shown to produce many other factors, now collectively
denoted as cytokines.
It is well established that lymphocyte activation by lectins
is initiated via binding to cell surface sugars, a fact verified
here for ArtinM and reinforcing a previous observation by
Benoist et al. (2009). We showed that the lectin binds on the
surface of non-separated spleen cells as well as on isolated
CD4+ T cells in a manner that depends on carbohydrate
recognition, because D-mannose selectively inhibited
ArtinM binding to the cell surface. Our preliminary results
showed that ArtinM binds to Jurkat cells through carbohy-
drate recognition (data not shown), as has been demonstrated
for Jacalin (Baba et al. 2007). Additional studies are underway
to analyze the mitogenic and/or cytotoxic effects of jArtinM
and rArtinM on human cells.
Clearly, binding to appropriately glycosylated receptors is
insufficient to stimulate lymphocytes. Mitogenic lectins set in
motion a signal transduction pathway that also functions on
the antigen-dependent activation of lymphocytes. The key
event in this pathway is protein tyrosine kinase activation,
which mediates interactions with adapter proteins in a process
that allows the enzymatic hydrolysis of phosphatidylinositol
4,5-biphosphate into diacylglycerol and inositol 1,4,5-triphos-
phate, both of which act as Ca++-dependent second messen-
gers. Subsequently, the activation of two major pathways that
involve Ras and protein kinase C results in the activation of
MAPKs and extracellular signal-regulated kinases 1 and 2.
Fig. 10 CD3 receptor as a glycotarget of ArtinM. (a–c) Purified CD4+ T
cells (1.5×106/mL) were fixed and incubated for 40 min with ArtinM
(25 μg/mL). After washing, the cells were incubated for 40 min with an
anti-CD3 PE-Cy5 antibody (10 μg/mL) and analyzed using flow cytom-
etry. The histograms represent the percentage of cells positive for staining
with the anti-CD3 PE-Cy5 antibody after preincubation with (b) or
without (a) ArtinM. d Isolated CD4+ T cells (1×106/mL) were incubated
with the anti-CD3 antibody (5 μg/mL) or an anti-CD28 antibody (5 μg/
mL) for 40 min and then stimulated with ArtinM (78 nM) for 48 h. IL-2
concentration in the culture supernatants was quantified by means of
ELISA, and the results are expressed asmean ± SEM; *p<0.05 compared
to the cells that were preincubatedwith vehicle (culture medium) and then
stimulated with ArtinM
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The concerted action of the signal amplification triggers bio-
chemical processes that result in the production and release of
IL-2 (Smith-Garvin et al. 2009). Using inhibitors of signaling
molecules, we showed that the increased mitochondrial activ-
ity and IL-2 production induced by ArtinM depend on the
signaling molecules mentioned above. Additional experi-
ments using purified T cells are necessary to further analyze
and demonstrate the involvement of these molecules.
Mitogenicity of ArtinM on human PBMCwere focused on
the very first reports of ArtinM biological properties (de
Miranda-Santos et al. 1991). Subsequent studies were primar-
ily motivated by the discovery that ArtinM administration
confers resistance against L. major infection in BALB/c mice
(Panunto-Castelo et al. 2001). The studies demonstrated that
ArtinM directly stimulates antigen-presenting cells to produce
IL-12, providing an apparently full rational basis for ArtinM
application as an efficient immunomodulatory agent.
Although mandatory, evaluation of the ArtinM direct effect
on cells of the adaptive immunity has been withdrawn.
Indeed, correlation between the properties of several plant
lectins of stimulating IL-12 production and inducing lymph
proliferation has been examined previously and showed that
only wheat germ agglutinin of Triticum vulgare induced IL-12
production without promoting cell proliferation or IL-2 re-
lease (Muraille et al. 1999). Here, we demonstrate that
ArtinM-induced proliferation of murine spleen cells is inde-
pendent of TLR2. Most of the lectins assayed by Muraille
et al. (1999), and now verified for ArtinM, have been shown
to stimulate both lymphocyte proliferation and IL-12 produc-
tion, suggesting that they recognize specific oligosaccharides
on the surface of the cells involved in adaptative and innate
immunity.
The sugar-binding specificity of lectins is due to a limited
segment of conserved amino acid residues that constitute their
CRD (Drickamer 1988; Sharon and Lis 2004). An appropriate
CRD structure is required from recombinant lectins to repro-
duce the sugar specificity of their native counterparts. This
requirement was satisfied by rArtinM, as verified by
glycoarray studies (Pranchevicius et al. 2012) and reinforced
by the similar kinetic rates and affinity equilibrium constants
provided by the interaction of jArtinM and rArtinM with N-
glycans of horseradish peroxidase glycoprotein (Pesquero
et al. 2010). However, they differ in terms of avidity owing
to diversity in their tertiary structures: jArtinM is organized as
a tetramer, whereas rArtinM is monomeric (Pranchevicius
et al. 2012). Nonetheless, these features are insufficient to
explain the distinct concentrations required of jArtinM and
rArtinM to activate spleen cells. The quotients between the
concentrations required to induce mitochondrial activity, IL-2
production, and cell proliferation are much higher (>30) than
that between the number of CRDs per jArtinM and rArtinM
molecule (=4). Regardless, these preparations stimulated the
same responses on spleen cells, and in vivo administration of
rArtinM was as effective as jArtinM in conferring protection
against P. brasiliensis (Coltri et al. 2008). We hypothesized
that ArtinM tetramer, as a multivalent ligand, has superior
efficiency owing to a greater capability to cluster receptors
on the cell surface in a process that optimizes the triggered cell
signaling, as reported for T cell receptor (TCR) containing
microclusters that generate and sustain T-cell activation
(Yokosuka et al. 2005).
To characterize the mechanisms of immunomodulation
induced by external agents, we must investigate the effect
they exert on immune cell populations. The various T CD4+
effector/regulatory subpopulations deserve special attention.
Naive CD4+ T cells may differentiate into any of several
lineages of Th cells (Th1, Th2, and Th17) or into induced
regulatory T cells. Th1 cells make interferon-γ as a signature
cytokine and are also IL-2 producers; in addition, IL-12,
mostly produced by antigen-presenting and natural killer cells,
plays a central role in Th1 differentiation (Zhu and Paul 2010).
In the case of ArtinM induced-Th1 immunity, the stimulus of
IL-12 production has been thoroughly examined. The present
study suggests that the Th1 immunity (known to be induced
in vivo by ArtinM) involves ArtinM’s direct effects on differ-
entiation of naive CD4+ T cells into the Th1 lineage. This is
because lectin binds to CD4+ T cells and induces IL-2 pro-
duction. This idea is reinforced by the observation that
jArtinM induces IFN-γ production by CD4+ T cells (data
not shown). Moreover, the mechanism of CD4+ T-cell activa-
tion by ArtinM involves interaction with CD3, which was
shown to be a functionally relevant glycotarget of ArtinM in
the process of activation of the lymphocytes. Although our
results do not rule out participation of other ArtinM
glycotargets in driving the activation of CD4+ T cells, we
can state that CD3 is an essential participant because its
blockage with a specific antibody inhibited the response to
ArtinM by more than 90 %.
In summary, our study shows that ArtinM binding to
murine spleen cells is followed by increased proliferation,
mitochondrial activity, and IL-2 production in a carbohydrate
recognition-dependent manner. CD4+ T cells are clearly
targeted by the lectin, providing a direct mechanism of induc-
ing Th1 immunity. It is added to the indirect mechanism
provided by ArtinM targeting of antigen-presenting cells,
which accounts for increased IL-12 production and stimula-
tion of Th1 differentiation. This double Th1 stimulation may
decisively contribute to the efficiency of the in vivo
immunomodulation induced by ArtinM administration. The
present work opens new perspectives in understanding the full
mechanism of immunomodulation induced by carbohydrate
recognition.
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